Jump to section
Koneksa's mission is to help new interventions quickly and safely reach the people who need them most.
51% employee growth in 12 months
The rise of wearable technology has been incredibly beneficial for healthcare, allowing more accurate research and treatment, and improving health outcomes across the board.
Koneksa is one of the commercial companies developing precisely the kind of tech that enables this progress. It focuses on remote biometric monitoring devices covering spirometry, actigraphy, gait and balance, and vital signs.
The company has recently onboarded its first Chief Medical Officer, as well as securing strong funding, which will help bolster the precision and penetration of its products alongside its affiliations across the research community.
Wearables are firmly positioned to lead the way in pharmaceutical and biotech developments. Moreover, interest is growing across the industry in remotely monitored trials, which allow for greater test pools from more diverse areas. Koneksa is seemingly onto a winning concept, and its growing number of commercial partnerships suggests it’s making steady headway.
Kirsty
Company Specialist at Welcome to the Jungle
Feb 2022
$45m
SERIES C
Sep 2020
$16m
SERIES B
Chris Benko
(CEO)Previously spent two decades at Merck, ultimately serving as the VP of Global Talent Management, and then Strategic Planning.